Crossmark

SMR-guided molecular subtyping and machine learning model reveals novel prognostic biomarkers and therapeutic targets in non-small cell lung adenocarcinoma

Crossref DOI link: https://doi.org/10.1038/s41598-025-85471-8

Published Online: 2025-01-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Baozhen

Yin, Yichen

Wang, Anqi

Liu, Weidi

Chen, Jing

Li, Tao
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82060663)

Key Research and Development Program of Ningxia (2023BEG02010)
License Information

Text and Data Mining valid from 2025-01-10

Version of Record valid from 2025-01-10
More Information

Article History

Received: 20 September 2024

Accepted: 3 January 2025

First Online: 10 January 2025

Declarations

:

: The authors declare no competing interests.

: All authors approved the final manuscript for publication.

Document is current

Any future updates will be listed below